Due to legal restrictions pertaining to use of Danish register-based data, these de-identified data are available only upon request from Statistics Denmark (<https://www.dst.dk/en/OmDS/organisation/TelefonbogOrg?kontor=13&tlfbogsort=sektion>), provided that relevant ethical and legal permissions have been obtained, and that the researchers meet the criteria for access to confidential data.

Introduction {#sec005}
============

Syncope episodes are frequent in both young and older adults, \[[@pone.0206936.ref001]--[@pone.0206936.ref003]\] and characterized by a total loss of consciousness due to transiently reduced cerebral blood flow with subsequent complete recovery. \[[@pone.0206936.ref004], [@pone.0206936.ref005]\] Nonetheless, episodes do often lead to falls, and syncope could be related to an increased risk of injuries. Falls and fall-related complications are a considerable public health concern in terms of morbidity, mortality, quality of life, and cost of health and social services, especially among older adults. \[[@pone.0206936.ref006]--[@pone.0206936.ref010]\]

Over the last decade, the overlap in symptoms of syncope and falls, particularly in older persons, has received growing attention. \[[@pone.0206936.ref011]--[@pone.0206936.ref013]\] A number of age-related factors (physiological and pathological), in combination with amnesia for loss of consciousness, and lack of a witness account, may confound the assessment of syncope. \[[@pone.0206936.ref014]\] Consequently, persons with syncope are likely to present with an unexplained fall rather than syncope. \[[@pone.0206936.ref015], [@pone.0206936.ref016]\] Moreover, several studies have observed high prevalence of cardiovascular conditions among older persons presenting with unexplained falls. \[[@pone.0206936.ref017]\] Some of these conditions, particularly carotid sinus syndrome and orthostatic hypotension, are observed risk factors for unexplained falls and fall injuries, and also important causes of syncope in the elderly. \[[@pone.0206936.ref018]--[@pone.0206936.ref021]\] Yet, evidence on the associations between syncope syndromes and falls or injuries is sparse and mainly based on cross-sectional studies in selected settings. One study among approximately 200 elderly patients with syncope reported a two-year incidence of fractures of 11%, but injury was a secondary outcome and further analysis was not undertaken. \[[@pone.0206936.ref022]\] Moreover, previous studies among adult patients with syncope report that 26% to 39% suffer from injuries in relation to their syncope episode, \[[@pone.0206936.ref023], [@pone.0206936.ref024]\] but whether this is exclusively in older adults is unknown.

We conducted a nationwide study of adult patients with a first-time diagnosis of syncope, to provide longitudinal population-based data on the association between syncope and subsequent fall-related injuries. Our objectives were to assess the risk of fall-related injuries following syncope and evaluate if physical injury in this population occurs predominantly in older adults, and to compare the risk of fall-related injuries following syncope with that of the general population.

Methods {#sec006}
=======

The study is a nationwide register-based cohort study from January 1, 1997 to December 31, 2013. The study was conducted in Denmark where health services are predominantly tax-funded, which ensures free access to healthcare for the entire population. Individual-level linkage of information between population-based registers is possible due to a unique and personal identification number, which is assigned to each resident at birth or upon immigration. \[[@pone.0206936.ref025]\]

Registers {#sec007}
---------

The Civil Registration System holds information on the date of birth, death, sex, and migration for all residents. \[[@pone.0206936.ref025]\] Data on medical history and outcomes were retrieved from discharge diagnoses and claimed prescriptions as appropriate. The Danish National Patient Register holds data on all hospitalizations since 1977. \[[@pone.0206936.ref026]\] At discharge, each hospital contact is registered with one principal diagnosis, and if appropriate, one or several supplementary diagnoses according to the International Classification of Diseases (ICD). The Danish Register of Medicinal Product Statistics comprises information about claimed prescriptions, and each drug dispensing is registered according to the Anatomical Therapeutic Chemical classification system. \[[@pone.0206936.ref027]\] Partial reimbursement of drug expenses by the national healthcare system ensures complete registration by the pharmacies. Average five-year household income prior to study start served as a proxy of socioeconomic status, and information was obtained from Statistics Denmark. \[[@pone.0206936.ref028]\]

Study population {#sec008}
----------------

The study population comprised all residents ≥18 years with a first-time primary discharge diagnosis of syncope between 1997 and 2012. Both inpatient and emergency department (ED) encounters were included. Subjects with prior syncope outpatient contacts were excluded. The reference group was obtained with risk set matching: Each subject in the syncope population was matched with one subject from the general population without prior syncope hospitalizations by year of birth and sex. The ICD diagnosis of syncope (10th revision code R55.9) refers to the most common etiologies of syncope, \[[@pone.0206936.ref005]\] and has previously been validated with a positive predictive value of 96%.\[[@pone.0206936.ref029]\]

Covariates {#sec009}
----------

Potential confounding factors were pre-specified and identification was based on current knowledge in combination with the construction of a model diagram. \[[@pone.0206936.ref030]\] The following medical variables were considered: cardiovascular disease (including ischemic heart disease or myocardial infarction, heart failure, cardiac arrhythmia, atrioventricular block or left bundle branch block, cerebral vascular disease, or peripheral vascular disease), pacemaker, diabetes mellitus, cancer, dementia, depression, Parkinson disease, and use of loop diuretic, antihypertensive, or anxiolytic drugs. Information was retrieved from diagnosis or surgical procedure codes up to ten years prior to inclusion, and from claimed prescriptions up to one year prior to inclusion ([S1 Table](#pone.0206936.s001){ref-type="supplementary-material"}). We considered combination treatment with at least two standard antihypertensive agents within a period of 90 days as use of antihypertensive drugs. \[[@pone.0206936.ref031]\] When appropriate, we combined diagnosis and prescription data of comorbidities such as diabetes mellitus, depression, and dementia, to increase the sensitivity of the covariates. Osteoporosis is a main risk factor of fragility-fractures, but because the association with syncope is unclear, it was not considered a principal confounder.

Study outcome {#sec010}
-------------

The primary outcome of a fall-related injury was defined as any hospital encounter (ED visit or inpatient admission) from fractures (femur, pelvis, shoulder or upper arm, elbow, forearm or wrist, and skull) or traumatic head injuries ([S1 Table](#pone.0206936.s001){ref-type="supplementary-material"}). The approach has been used previously as a proxy for serious falls. \[[@pone.0206936.ref009]\] The outcome of interest was post-discharge injuries, so documentation of an injury in relation to the syncope episode was not considered as an event (but evaluated in supplementary analyses). The study population was followed for one year, or until the occurrence of a fall-related injury, emigration, or death.

Statistics {#sec011}
----------

Differences in baseline characteristics were compared using chi-squared test for categorical variables. We report loss to follow-up at one year. The level of significance was set at 5%. To assess the time-dependent absolute risk of fall-related injuries following syncope, we used the Aalen-Johansen estimator to account for the competing risk of death. \[[@pone.0206936.ref032]\] Furthermore, we report one-year risks separately for the syncope and reference group and according to age at baseline. The relation between the absolute risks and age (continuous scale) was obtained with the Aalen-Johansen estimate and kernel smoothing.

In our main analysis, we performed absolute risk regression analysis, \[[@pone.0206936.ref033]\] and report absolute risk ratios (ARR) with 95% confidence intervals (CI) referring to the probability of sustaining a fall-related injury during the next year for persons with syncope compared to persons without syncope, given fixed values for the other predictor variables. Models were adjusted for age (five-year intervals), sex, calendar year (four-year intervals), and socioeconomic status in addition to comorbidities and pharmacotherapies. Effect modification was analyzed in subgroups defined by clinical relevance, thus the syncope-associated one-year risks of fall-related injuries were estimated in subgroups defined by age, sex, cardiovascular disease, arrhythmia, pacemaker, loop diuretic use, depression, and fall-related injury in the past 12 months. We further analyzed absolute risk ratios to associate changes in one-year risk of fall-related injuries with differences in person characteristics in the syncope population.

Sensitivity analyses adjusted for osteoporosis and prior fall-related injury respectively, and in another analysis, we excluded all patients with fall-related injury in relation to the syncope episode. We also examined whether the risk was similar for patients with syncope who were admitted to hospital and patients discharged from the ED. All analyses were repeated with hip fracture as the outcome of interest; specifically, because hip fractures are both highly correlated with falls, and require hospitalization. Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Gary, NC, USA) and R version 3.4. \[[@pone.0206936.ref034]\]

### Ethics {#sec012}

The study was approved by the Danish Data Protection Agency (ref. number: 2007-58-0015 / GEH-2014-013 I-Suite number: 02731). In Denmark, ethical approval is not required for retrospective register-based studies. All analyses were executed on servers placed at Statistics Denmark.

Results {#sec013}
=======

In the period from 1997 through 2012, 125,763 adult patients with a first-time diagnosis for syncope were identified (n = 8288 were excluded due to prior syncope outpatient contacts), of which 68,671 (54.6%) represented inpatient admissions. The median age of patients with syncope was 65 years (interquartile range \[IQR\] 46--78) and 65,608 (52.2%) were women ([Table 1](#pone.0206936.t001){ref-type="table"}). The most prevalent comorbidities were ischemic heart disease (n = 20,093, 16.0%), arrhythmia (n = 15,673, 12.5%), and depression (n = 22,415, 17.8%). Prevalence of comorbidities was greater in the syncope population compared with the matched reference group, as was the frequency of a prior fall-related injury (n = 7912, 6.3% versus n = 3774, 3.0%, P\<0.001).

10.1371/journal.pone.0206936.t001

###### Baseline characteristics of the study population[^a^](#t001fn002){ref-type="table-fn"}^,^ [^b^](#t001fn003){ref-type="table-fn"}.

![](pone.0206936.t001){#pone.0206936.t001g}

                                                                  Syncope (n = 125,763)   No syncope (n = 125,763)
  --------------------------------------------------------------- ----------------------- --------------------------
  Age, median \[IQR\], years                                      65 \[46--78\]           65 \[46--78\]
  Age groups, years                                                                       
   18--49                                                         35,213 (28.0)           35,213 (28.0)
   50--64                                                         26,292 (20.9)           26,292 (20.9)
   65--79                                                         36,153 (28.7)           36,153 (28.7)
   ≥80                                                            28,105 (22.3)           28,105 (22.3)
  Women                                                           65,608 (52.2)           65,608 (52.2)
  Men                                                             60,155 (47.8)           60,155 (47.8)
  Income group[^c^](#t001fn004){ref-type="table-fn"}, quartiles                           
   \<First quartile                                               24,933 (19.8)           25,372 (20.2)
   First to third quartile                                        78,049 (62.1)           72,867 (57.9)
   \>Third quartile                                               22,781 (18.1)           27,524 (21.9)
  Comorbidity                                                                             
   Cardiovascular disease                                         40,659 (32.3)           20,031 (15.9)
   Ischemic heart disease or MI                                   20,093 (16.0)           9428 (7.5)
   Heart failure                                                  9053 (7.2)              4033 (3.2)
   Cardiac arrhythmia                                             15,673 (12.5)           6679 (5.3)
   Atrial fibrillation                                            11,688 (9.3)            5339 (4.2)
   AV block or LBBB                                               2576 (2.0)              691 (0.5)
   Cerebral vascular disease                                      12,875 (10.2)           5755 (4.6)
   Pacemaker                                                      3700 (2.9)              937 (0.7)
   Diabetes mellitus                                              10,500 (8.3)            7123 (5.7)
   Cancer                                                         10,378 (8.3)            7953 (6.3)
   Depression                                                     22,415 (17.8)           12,806 (10.2)
   Parkinson disease                                              2760 (2.2)              1499 (1.2)
   Dementia                                                       3981 (3.2)              2097 (1.7)
   Osteoporosis                                                   5892 (4.7)              4779 (3.8)
  Pharmacotherapy                                                                         
   Antihypertensive drugs                                         37,865 (30.1)           25,480 (20.3)
   Loop diuretic drugs                                            17,910 (14.2)           11,330 (9.0)
   Anxiolytic drugs                                               27,041 (21.5)           18,332 (14.6)
  Fall-injury in past 12 m                                        7912 (6.3)              3774 (3.0)
  Syncope inpatient admission                                     68,671 (54.6)           NA
  Syncope ED visit                                                57,092 (45.4)           NA
  Syncope and injury[^d^](#t001fn005){ref-type="table-fn"}        4601 (3.7)              NA
  Year of inclusion                                                                       
   1997--2000                                                     29,776 (23.7)           29,776 (23.7)
   2001--2004                                                     32,640 (26.0)           32,640 (26.0)
   2005--2008                                                     31,171 (24.8)           31,171 (24.8)
   2009--2012                                                     32,176 (25.6)           32,176 (25.6)

Abbreviations: IQR (interquartile range), MI (myocardial infarction), LBBB (left bundle branch block), ED (emergency department), NA (not applicable)

^a^Data are expressed as no. (%) unless otherwise indicated

^b^P values were \<0.001 (except for age and sex)

^c^Average five-year household income prior to inclusion

^d^Documented fall-related injury in relation to the syncope episode

Absolute one-year risk of fall-related injuries following syncope {#sec014}
-----------------------------------------------------------------

At one year, follow-up was complete for 99.8% of the syncope population (n = 199, 0.2% emigrated). A total of 8394 (6.7%, 95% CI, 6.6%-6.8%) patients had a fall-related injury requiring re-hospitalization, whereas 4049 (3.2%, 95% CI, 3.1%-3.3%) persons in the reference group had a fall-related injury ([Fig 1](#pone.0206936.g001){ref-type="fig"}). Hip fracture accounted for one out of five injury hospitalizations among persons with syncope (n = 1606, 19.1%) compared with n = 1016 in the reference group ([S2 Table](#pone.0206936.s002){ref-type="supplementary-material"}). [Fig 2](#pone.0206936.g002){ref-type="fig"} shows the absolute one-year risks of fall-related injuries according to age in the syncope and reference population respectively. The absolute risk of a fall-related injury increased with advancing age, and was particularly high among elderly women; however, young men did also have a substantial risk of injury.

![Absolute risk of hospitalization due to fall-related injuries following syncope.\
Syncope population (red), matched reference group (black). One-year absolute risk of fall-related injuries was 6.7% (95% CI, 6.5%-6.8%) in the syncope population, and 3.2% (95% CI, 3.1%-3.3%) in the age- and sex matched reference group.](pone.0206936.g001){#pone.0206936.g001}

![Absolute one-year risks of fall-related injuries according to age.\
Absolute one-year risks of fall-related injuries according to age at syncope accounting for the competing risk of death in the syncope (red) and matched reference population (black) respectively. Selected point estimates with 95% CI are shown.](pone.0206936.g002){#pone.0206936.g002}

Risk of fall-related injuries in patients with syncope compared to persons without syncope {#sec015}
------------------------------------------------------------------------------------------

The one-year adjusted ARR of fall-related injuries was 1.79 (95% CI, 1.72--1.87, P\<0.001) in patients with syncope compared with the reference group (unadjusted ARR, 1.85, 95% CI, 1.78--1.93, P\<0.001). [Fig 3](#pone.0206936.g003){ref-type="fig"} presents risk estimates stratified by age and sex. We found that the ARR decreased with advancing age. Also, in the older age groups, the relative importance of syncope was greater in men (65--79 years: ARR, 2.42, 95% CI, 2.11--2.77) compared with women (65--79 years: ARR, 1.73, 95% CI, 1.56--1.93). [S1 Fig](#pone.0206936.s003){ref-type="supplementary-material"} provides a summary of subgroup analyses. The syncope-associated one-year risks of fall-related injuries were increased across subgroups, with the exception of patients with pacemaker (ARR, 1.19, 95% CI, 0.89--1.59, P = 0.23) versus no pacemaker (ARR, 1.81, 95% CI, 1.73--1.88, P\<0.001).

![One-year absolute risk ratios of fall-related injuries in the syncope population compared with the reference.\
The matched group without prior syncope served as reference within each stratum. Multiple absolute risk regression analyses with adjustment for: age, sex, socioeconomic status, calendar year, ischemic heart disease, arrhythmia, atrioventricular block or left bundle branch block, pacemaker, use of antihypertensive, loop diuretic or anxiolytic drugs, depression, diabetes, cancer, Parkinson disease, and dementia. Number of events refers to observed events within one year. ARR indicates absolute risk ratio.](pone.0206936.g003){#pone.0206936.g003}

Characteristics associated with one-year risk of fall-related injuries {#sec016}
----------------------------------------------------------------------

The three factors most associated with increased ARR of fall-related injuries in the syncope population were: fall-related injury in past 12 months (2.39, 95% CI, 2.26--2.53, P\<0.001), fall-related injury in relation to the syncope episode (1.62, 95% CI, 1.49--1.77, P\<0.001), and depression (1.37, 95% CI, 1.30--1.45, P\<0.001), whereas high socioeconomic status, and use of antihypertensive drugs were associated with decreased one-year risk of fall-related injuries ([Fig 4](#pone.0206936.g004){ref-type="fig"}).

![Person characteristics associated with one-year absolute risk ratios of fall-related injuries in the syncope population.\
Multiple absolute risk regression analysis was done to associate changes in one-year risks of subsequent fall-related injuries with person characteristics. ARR indicates absolute risk ratio, LBBB left bundle branch block, and SES socioeconomic status. Syncope and injury refers to a documented injury in relation to the syncopal event.](pone.0206936.g004){#pone.0206936.g004}

Sensitivity analyses {#sec017}
--------------------

The syncope-associated one-year risk of fall-related injuries was similar for patients seen in the ED (ARR, 1.84, 95% CI, 1.72--1.96, P\<0.001) and patients admitted to hospital (ARR, 1.77, 95% CI, 1.68--1.87, P\<0.001). Adjustment for osteoporosis did not challenge the results from the main analysis (ARR, 1.79, 95% CI, 1.72--1.86, P\<0.001), neither did adjustment for prior fall-related injury (ARR, 1.72, 95% CI, 1.65--1.80, P\<0.001), or exclusion of patients with fall-related injury in relation to their syncope episode (ARR, 1.74, 95% CI, 1.67--1.81, P\<0.001). Moreover, the main analysis was repeated with hip fracture as outcome, but yielded similar results among subjects' ≥65 years (the analysis could not be executed in younger subjects due to a limited number of events), [S2 Fig](#pone.0206936.s004){ref-type="supplementary-material"}.

Discussion {#sec018}
==========

The main finding of the study was that first-time syncope was associated with 80% increased one-year risk of fall-related injuries, in terms of fractures and traumatic head injuries requiring hospitalization, compared with an age- and sex matched reference group. The study is the first to provide comprehensive longitudinal data on injury risk in a real-world clinical setting of adult patients with syncope. Although the absolute risk increased with advancing age, the relative risk of fall-related injuries associated with syncope decreased in the elderly. Plausibly, because multiple factors influence fall-injury risk in older persons the attributable risk associated with syncope decreases with advancing age. Notably, increased risk of injury was not exclusively in older patients, but also substantially increased in young adults with syncope. Depression, prior fall-related injury, and injury in relation to the syncope episode were important risk factors associated with increased risk of sustaining a fall-related injury.

Our observation of increasing absolute risk of fall-related injuries with advancing age, particularly in older women is in line with current knowledge. \[[@pone.0206936.ref009], [@pone.0206936.ref035], [@pone.0206936.ref036]\] Medical conditions and physiological changes associated with aging such as impairment in cognition and declines in balance, gait, and muscle strength, contribute to an increased likelihood of falls amongst older adults. \[[@pone.0206936.ref036], [@pone.0206936.ref037]\] In addition, bone fragility such as osteoporosis increases susceptibility to serious injury. \[[@pone.0206936.ref038]\] Both sarcopenia (age-associated loss of skeletal muscle mass and function) and bone fragility accelerates in association with menopause-related estrogen-deficiency, \[[@pone.0206936.ref039]\] which could explain the difference in relative risk observed between men and women with syncope in the older age groups.

Although the majority of injuries were observed in the elderly population, younger patients with a history of syncope also had markedly increased risk of injury. However, the injury mechanism is liable to be different in younger and older adults, and while the injuries identified in the current study are strongly related to falls in older adults, \[[@pone.0206936.ref040]\] other causes may predominate in younger adults such as transportation, work, and sport or leisure activities.\[[@pone.0206936.ref035]\] Information pertaining to the specific circumstances of the sustained injuries was unavailable in the current study.

Our findings are in keeping with prior research on the association of some individual causes of syncope and unexplained falls and fall injuries in older persons.\[[@pone.0206936.ref018],[@pone.0206936.ref019],[@pone.0206936.ref021],[@pone.0206936.ref041]\] One study observed that amongst older persons with dementia, roughly 50% of individuals initially referred for an unexplained fall was eventually diagnosed with syncope, with orthostatic hypotension as the most common cause.\[[@pone.0206936.ref042]\] Similarly, it has been reported that prevalence of CSS is common in older persons referred to ambulatory management for unexplained falls, ranging from 14% to 27%.\[[@pone.0206936.ref020],[@pone.0206936.ref041],[@pone.0206936.ref043]\] Comparisons of our risk estimates regarding the effect of syncope with previous studies remain difficult due to substantial differences in study design, setting, and demographics of the study population.

With advancing age, the attributable risk of cardiac causes of syncope increases. We observed that in patients with a cardiac pacemaker, syncope was not significantly associated with risk of subsequent fall-related injuries. This is in line with a study, which demonstrated a substantial reduction in the number of injurious events amongst individuals with cardio-inhibitory carotid sinus hypersensitivity randomized to pacing.\[[@pone.0206936.ref044]\] However, conflicting results have been observed for effects of pacing intervention on fall-rates.\[[@pone.0206936.ref045]\] Furthermore, atrial fibrillation has been associated with syncope and falls.\[[@pone.0206936.ref046], [@pone.0206936.ref047]\] In one study among older adults presenting with unexplained falls, 71% had an incident cardiac arrhythmia within less than a year using an implantable loop recorder, and in 20% a recurrent fall and/or syncope was directly attributable to the arrhythmia. \[[@pone.0206936.ref048]\] In contrast with these observations, we demonstrated that the syncope-associated risk of fall-related injuries was relatively lower among persons with pre-existing arrhythmias and cardiovascular disease in general. However, register-based data could be subject to ascertainment bias i.e. the probability of receiving a specific cardiac diagnosis over a non-specific syncope diagnosis could be increased in more grievous cases.

Although a single cause is evident in a minority of falls, a multitude of factors, such as environmental factors, acute and chronic medical conditions, and medications are likely to influence the risk of falling. \[[@pone.0206936.ref036], [@pone.0206936.ref049]\] Medications with orthostatic effects, such as antihypertensive, diuretic, and psychotropic drugs, have repeatedly been associated with both syncope and falls. \[[@pone.0206936.ref050]--[@pone.0206936.ref052]\] In contrast, we observed that use of antihypertensive and loop diuretic drugs was not associated with increased risk in patients with syncope; however, dose changes were not accounted for and could be a possible explanation. Moreover, the additive effects of multiple present risk factors were out of the scope of the current study. In one study, \[[@pone.0206936.ref037]\] the probability of (recurrent) falls increased from 3% amongst persons with no documented risk factors to 84% among persons with five or more risk factors indicating that modifying even a few factors may reduce the risk of fall-related injuries. Cardiovascular assessment is fundamental in the evaluation of patients with syncope, but perhaps a more extensive assessment is required in some patients. Our results demonstrating that depression, use of anxiolytic drugs, dementia, and prior injury were associated with subsequent re-hospitalization due to fall-related injuries could plausibly indicate that a more multifactorial and interdisciplinary approach needs to be considered in the elderly and patients with multimorbidity.\[[@pone.0206936.ref004], [@pone.0206936.ref053], [@pone.0206936.ref054]\] Establishment of formal syncope management facilities could be one way to ensure standardized and appropriate management of patients with syncope, despite the heterogeneous patient group composition, but further research is required. \[[@pone.0206936.ref055]\]

Strengths and limitations {#sec019}
-------------------------

The main strength of this study was the use of nationwide registers that enabled identification and complete follow-up of a large cohort of patients with syncope irrespective of age, morbidity, socioeconomic status, and health insurance schemes, and with independent data collection of outcomes. However, the study has several potential limitations. First, due to the observational design, direct conclusions on causal relationships of our findings remain unviable. Second, important clinical parameters including blood pressure, electrocardiographic, echocardiographic or carotid sinus massage findings were unavailable in the registries, so despite extensive adjustments for potential confounding factors, we cannot exclude effects of residual confounding. Furthermore, the ICD registration does not specify the etiologies of syncope; consequently, we do not address effect measures attributable to specific causes of syncope. Instead, we have evaluated subgroups, mainly within different cardiovascular conditions. Third, we cannot exclude the possibility that persons who contact the ED or hospital due to syncope may be inherently different from those who do not; however, effect measures of hip fracture, which should always lead to hospitalization, supported the main results. Of note, the reported risk of fall-related injuries only reflects the number of injury events coming to acute medical attention at EDs and hospitals, and may, therefore, represent an underestimate of total fall-related events. Information pertaining to fatal fall incidents resulting in immediate death prior to hospitalization was unavailable.

Conclusions {#sec020}
-----------

In this nationwide study, adult patients with first-time syncope were at 80% increased risk of severe fall-related injuries within the year following discharge. Notably, increased risk was not exclusively in older patients. These findings underscore the necessity of increased clinical awareness about traumatic injury risk and appropriate management of patients with syncope of all ages in clinical practice, and support increased multidisciplinary assessment in falls-prevention among older adults. Further cohort and intervention studies will be needed to reveal causal effects and efficacy of preventive strategies.

Supporting information {#sec021}
======================

###### Specific codes used to describe the study population and to identify endpoints.

(PDF)

###### 

Click here for additional data file.

###### Summary of fall-related injures within one year.

(PDF)

###### 

Click here for additional data file.

###### Subgroup analyses of the one-year absolute risk ratios of fall-related injuries between syncope population and reference.

The age- and sex matched group without prior syncope served as reference in all analyses. Multiple absolute risk regression analyses with adjustment for: age, sex, calendar year, socioeconomic status, comorbidities, and pharmacotherapy. ARR indicates absolute risk ratio.

(PDF)

###### 

Click here for additional data file.

###### One-year absolute risk ratio of hip fractures in the syncope population ≥65 years compared with the reference.

The age- and sex matched group ≥65 years served as reference. Multiple absolute risk regression analyses with adjustment for: age, sex, calendar year, socioeconomic status, ischemic heart disease, arrhythmia, atrioventricular block or left bundle branch block, pacemaker, use of antihypertensive, loop diuretic or anxiolytic drugs, depression, diabetes, cancer, Parkinson disease, and dementia. ARR for total fall-related injury is provided for comparative purpose. ARR indicates absolute risk ratio.

(PDF)

###### 

Click here for additional data file.
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